These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21330267)

  • 1. Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation.
    Zbikowski SM; Jack LM; McClure JB; Deprey M; Javitz HS; McAfee TA; Catz SL; Richards J; Bush T; Swan GE
    Nicotine Tob Res; 2011 May; 13(5):319-27. PubMed ID: 21330267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phone and web-based tobacco cessation treatment: real-world utilization patterns and outcomes for 11,000 tobacco users.
    Zbikowski SM; Hapgood J; Smucker Barnwell S; McAfee T
    J Med Internet Res; 2008 Nov; 10(5):e41. PubMed ID: 19017583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral counseling and varenicline treatment for smoking cessation.
    Swan GE; McClure JB; Jack LM; Zbikowski SM; Javitz HS; Catz SL; Deprey M; Richards J; McAfee TA
    Am J Prev Med; 2010 May; 38(5):482-90. PubMed ID: 20409497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to varenicline in the COMPASS smoking cessation intervention trial.
    Catz SL; Jack LM; McClure JB; Javitz HS; Deprey M; Zbikowski SM; McAfee T; Richards J; Swan GE
    Nicotine Tob Res; 2011 May; 13(5):361-8. PubMed ID: 21350041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of a Web-based vs integrated phone/Web cessation program among 140,000 tobacco users: an evaluation across 10 free state quitlines.
    Nash CM; Vickerman KA; Kellogg ES; Zbikowski SM
    J Med Internet Res; 2015 Feb; 17(2):e36. PubMed ID: 25673013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative and cost effectiveness of telemedicine versus telephone counseling for smoking cessation.
    Richter KP; Shireman TI; Ellerbeck EF; Cupertino AP; Catley D; Cox LS; Preacher KJ; Spaulding R; Mussulman LM; Nazir N; Hunt JJ; Lambart L
    J Med Internet Res; 2015 May; 17(5):e113. PubMed ID: 25956257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study).
    Carson KV; Smith BJ; Brinn MP; Peters MJ; Fitridge R; Koblar SA; Jannes J; Singh K; Veale AJ; Goldsworthy S; Litt J; Edwards D; Hnin KM; Esterman AJ
    Nicotine Tob Res; 2014 Nov; 16(11):1495-502. PubMed ID: 25031315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.
    Halperin AC; McAfee TA; Jack LM; Catz SL; McClure JB; Deprey TM; Richards J; Zbikowski SM; Swan GE
    J Subst Abuse Treat; 2009 Jun; 36(4):428-34. PubMed ID: 19004600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
    Aubin HJ; Bobak A; Britton JR; Oncken C; Billing CB; Gong J; Williams KE; Reeves KR
    Thorax; 2008 Aug; 63(8):717-24. PubMed ID: 18263663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience of varenicline for smoking cessation.
    Jung JW; Jeon EJ; Kim JG; Yang SY; Choi JC; Shin JW; Park IW; Choi BW; Kim DK; Kim JY
    Clin Respir J; 2010 Oct; 4(4):215-21. PubMed ID: 20887344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model.
    Knight C; Howard P; Baker CL; Marton JP
    Value Health; 2010; 13(2):209-14. PubMed ID: 19912599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internet and Telephone Treatment for smoking cessation: mediators and moderators of short-term abstinence.
    Graham AL; Papandonatos GD; Cobb CO; Cobb NK; Niaura RS; Abrams DB; Tinkelman DG
    Nicotine Tob Res; 2015 Mar; 17(3):299-308. PubMed ID: 25156528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP
    J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internet versus in-person counseling for patients taking varenicline for smoking cessation.
    Dezee KJ; Wink JS; Cowan CM
    Mil Med; 2013 Apr; 178(4):401-5. PubMed ID: 23707824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009670. PubMed ID: 23235680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation: an overview of treatment options with a focus on varenicline.
    Stack NM
    Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.